Actym Therapeutics Appoints Thomas Smart as CEO
BERKELEY, CA — April 24, 2024 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Officer. With 25 years of experience in senior management and executive roles as well as Board of Directors positions across the biopharmaceutical industry, Mr. Smart brings a significant […]
Article Date
April 24, 2024
This article is featured on another website.
Go to article
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…